Mode
Text Size
Log in / Sign up

Gastroenterology

197 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Rituximab exposure is associated with serum sickness in patients with multiple sclerosis, nephrotic syndrome, or immune thrombocytopenia.
Gastroenterology Cohort
Rituximab exposure is associated with serum sickness in patients with multiple sclerosis, nephrotic syndrome, or immune thrombocytopenia. Can taking Rituximab cause a severe allergic reaction that returns if you take it again?
This retrospective review analyzed 39 published case reports of patients with rituximab-induced serum sickness (RISS). The study describes c…
Taking Rituximab can trigger a delayed allergic reaction that returns in most patients if the drug is given again, so doctors must use extre…
Phase I trial of regorafenib plus ipilimumab and nivolumab shows 27.6% response in MSS colorectal cancer
Gastroenterology Phase I
Phase I trial of regorafenib plus ipilimumab and nivolumab shows 27.6% response in MSS colorectal cancer Who Really Responds to a Stubborn Colon Cancer Combo?
A phase I trial in 29 patients with microsatellite-stable metastatic colorectal cancer tested the combination of regorafenib, ipilimumab, an…
A three-drug combo helped some patients with stubborn colon cancer, and immune markers now predict who will benefit most.
Single-cell sequencing reveals T cell clonal patterns in healthy donors and ulcerative colitis patients.
Gastroenterology
Single-cell sequencing reveals T cell clonal patterns in healthy donors and ulcerative colitis patients. T Cells Move Freely in Colon, Not Just in Blood
This observational study analyzed 333,088 T cells from healthy donors and ulcerative colitis (UC) patients using single-cell T cell receptor…
T cells in the colon travel freely across the gut, not just in the blood, reshaping how we understand immune health in conditions like ulcer…
Meta-analysis finds exercise training reduces intrahepatic lipids and improves metabolic markers in NAFLD
Gastroenterology Meta-analysis
Meta-analysis finds exercise training reduces intrahepatic lipids and improves metabolic markers in NAFLD Which Workout Melts Liver Fat Fastest? New Rankings Are In
A systematic review and meta-analysis of 1,880 adults with NAFLD found exercise training significantly reduced intrahepatic lipids (SMD: -0.…
A fresh look at 38 trials shows exercise reliably trims liver fat and improves blood sugar, with HIIT leading the pack.
Hepatitis E vaccine linked to elevated spontaneous abortion risk when given 31-60 days before pregnancy
Gastroenterology RCT
Hepatitis E vaccine linked to elevated spontaneous abortion risk when given 31-60 days before pregnancy A Vaccine's Hidden Risk Window for Early Pregnancy Loss
An RCT in women vaccinated during or shortly before pregnancy found an elevated risk of spontaneous abortion (Relative Risk 4.3) in HEV239 r…
A Hepatitis E vaccine given one to two months before pregnancy is linked to a higher risk of miscarriage, forcing doctors to rethink timing …
Blood group B alleles associated with increased MIS-C risk in Italian children cohort study
Gastroenterology Cohort
Blood group B alleles associated with increased MIS-C risk in Italian children cohort study Why Blood Type B May Raise One Rare COVID Risk in Kids
A cohort study of 18 Italian children with MIS-C or Kawasaki-like disease found blood group B alleles conferred increased risk (OR 2.9). All…
A small study suggests that blood type and inherited immune differences may help explain which children get the rare post-COVID inflammatory…
Machine learning models show moderate to high accuracy for predicting variceal bleeding in cirrhosis patients
Gastroenterology Meta-analysis
Machine learning models show moderate to high accuracy for predicting variceal bleeding in cirrhosis patients New AI Tool Catches Bleeding Risks Early
A systematic review and meta-analysis of 21 studies involving 7,011 cirrhosis patients found machine learning models achieved pooled c-indic…
An AI tool now spots bleeding risks in liver disease earlier than current methods, helping doctors catch dangerous vein swelling before it t…
SBRT plus PD-1 inhibitor and lenvatinib improved PFS in oligoprogressive HCC patients.
Gastroenterology Phase II
SBRT plus PD-1 inhibitor and lenvatinib improved PFS in oligoprogressive HCC patients. Radiation Plus Immune Drugs Stops Liver Cancer Growth
This prospective Phase 2 study evaluated stereotactic body radiation therapy (SBRT) combined with continued first-line PD-1 inhibitor-based …
Combining targeted radiation with ongoing immune therapy can restart cancer control in patients whose disease was slowly spreading again.
Phase 2 trial of JNJ-73763989-based regimen shows no HBsAg seroclearance at primary endpoint in HBeAg-positive CHB
Gastroenterology Phase II
Phase 2 trial of JNJ-73763989-based regimen shows no HBsAg seroclearance at primary endpoint in HBeAg-positive CHB New combo lowers hepatitis B virus levels
A phase 2 trial in 54 treatment-naïve, HBeAg-positive chronic hepatitis B patients tested a regimen of JNJ-73763989 ± bersacapavir with nucl…
A new drug combination successfully lowered virus levels in many patients, though clearing the virus completely happened in only about one o…
Vitamin D supplementation associated with improved metabolic markers in patients with Metabolic-Associated Fatty Liver Disease.
Gastroenterology Meta-analysis
Vitamin D supplementation associated with improved metabolic markers in patients with Metabolic-Associated Fatty Liver Disease. A Simple Vitamin May Help Your Body Manage a Fatty Liver
This systematic review and meta-analysis evaluated 21 studies involving patients with Metabolic-Associated Fatty Liver Disease (MAFLD) recei…
Vitamin D supplements improved blood sugar, cholesterol, and liver health in people with fatty liver disease, offering a simple add-on to he…
Wearable monitoring characterizes autonomic dysfunction in hypermobile Ehlers-Danlos syndrome compared to healthy controls.
Gastroenterology Cohort
Wearable monitoring characterizes autonomic dysfunction in hypermobile Ehlers-Danlos syndrome compared to healthy controls. Wearable Watch Could End Years of Waiting for hEDS Diagnosis
This prospective cohort study enrolled 30 individuals with hypermobile Ehlers-Danlos syndrome (hEDS) and 28 healthy controls. Participants w…
A smartwatch can spot the hidden physical changes of hypermobile Ehlers-Danlos Syndrome (hEDS) much faster than current methods.
Nurse-assisted outpatient follow-up reduces 30-day readmissions but not mortality in decompensated cirrhosis
Gastroenterology Meta-analysis
Nurse-assisted outpatient follow-up reduces 30-day readmissions but not mortality in decompensated cirrhosis Nurse Care Cuts Hospital Returns for Liver Patients
A meta-analysis of 668 patients with decompensated liver cirrhosis found nurse-assisted outpatient follow-up significantly reduced 30-day re…
Adding nurses to liver care teams significantly cuts 30-day hospital readmissions and improves outcomes for patients with advanced liver dis…